Activation of AMP-activated protein kinase α1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Human Molecular Genetics

• Publication date

  2015-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddu497PMID 25256353
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutant TDP-43 Deregulates AMPK Activation by PP2A in ALS Models

  2014cited by this paper
• Therapeutic modulation of eIF2α-phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models

  2013cited by this paper
• Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

  2013cited by this paper
• Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis

  2013cited by this paper
• The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons.

  2013cited by this paper
• Similar dose-dependence of motor neuron cell death caused by wild type human TDP-43 and mutants with ALS-associated amino acid substitutions

  2013cited by this paper
• The epidemiology of ALS: a conspiracy of genes, environment and time

  2013cited by this paper
• Aberrant Localization of FUS and TDP43 Is Associated with Misfolding of SOD1 in Amyotrophic Lateral Sclerosis

  2012cited by this paper
• Lost in Transgenesis: A User's Guide for Genetically Manipulating the Mouse in Cardiac Research

  2012cited by this paper
• AMPK: a nutrient and energy sensor that maintains energy homeostasis

  2012cited by this paper
• Energy dysfunction in Huntington’s disease: insights from PGC-1α, AMPK, and CKB

  2012cited by this paper
• Molecular Signatures of Amyotrophic Lateral Sclerosis Disease Progression in Hind and Forelimb Muscles of an SOD1G93A Mouse Model

  2012cited by this paper
• Reduced Activity of AMP-Activated Protein Kinase Protects against Genetic Models of Motor Neuron Disease

  2012cited by this paper
• Cell stress induces TDP-43 pathological changes associated with ERK1/2 dysfunction: implications in ALS

  2011cited by this paper
• AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathies

  2011cited by this paper
• Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease

  2011cited by this paper
• Familial versus sporadic amyotrophic lateral sclerosis--a false dichotomy?

  2011cited by this paper
• Hyperphosphorylation as a Defense Mechanism to Reduce TDP-43 Aggregation

  2011cited by this paper
• A New Drug Design Targeting the Adenosinergic System for Huntington's Disease

  2011cited by this paper
• Metformin Treatment Has No Beneficial Effect in a Dose-Response Survival Study in the SOD1G93A Mouse Model of ALS and Is Harmful in Female Mice

  2011cited by this paper
• Design and Synthesis of Novel Dual‐Action Compounds Targeting the Adenosine A2A Receptor and Adenosine Transporter for Neuroprotection

  2011cited by this paper
• Redox signalling directly regulates TDP‐43 via cysteine oxidation and disulphide cross‐linking

  2011cited by this paper
• TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

  2010cited by this paper
• TDP‐43 Redistribution is an Early Event in Sporadic Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Hydrogen peroxide inhibits mTOR signaling by activation of AMPKα leading to apoptosis of neuronal cells

  2010cited by this paper
• Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.

  2010cited by this paper
• The neurobiology of amyotrophic lateral sclerosis

  2010cited by this paper
• Hydrogen peroxide stimulates nuclear import of the POU homeodomain protein Oct-1 and its repressive effect on the expression of Cdx-2

  2010cited by this paper
• Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis

  2010cited by this paper
• Nuclear factor TDP‐43 can affect selected microRNA levels

  2010cited by this paper
• Progressive motor weakness in transgenic mice expressing human TDP-43.

  2010cited by this paper
• Traffic control at the nuclear pore

  2010cited by this paper
• Clinical trials for neuroprotection in ALS.

  2010cited by this paper
• Impaired water reabsorption in mice deficient in the type VI adenylyl cyclase (AC6)

  2010cited by this paper
• Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?

  2009cited by this paper
• Standards of medical care in diabetes--2007.

  2009cited by this paper
• Another gene for ALS

  2009cited by this paper
• Dissecting the Signaling Events That Impact Classical Nuclear Import and Target Nuclear Transport Factors

  2009cited by this paper
• Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporin-mediated nuclear transport

  2009cited by this paper
• Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.

  2009cited by this paper
• Standards of Medical Care in Diabetes—2009

  2009cited by this paper
• Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP‐43

  2009cited by this paper
• Revisiting oxidative damage in ALS: microglia, Nox, and mutant SOD1.

  2008cited by this paper
• TDP‐43, the signature protein of FTLD‐U, is a neuronal activity‐responsive factor

  2008cited by this paper
• Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.

  2007cited by this paper
• AMP-activated protein kinase signaling in metabolic regulation.

  2006cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006cited by this paper
• AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes.

  2006cited by this paper
• AMP-activated protein kinase-regulated phosphorylation and acetylation of importin alpha1: involvement in the nuclear import of RNA-binding protein HuR.

  2004cited by this paper
• AMP-Activated Kinase Regulates Cytoplasmic HuR

  2002cited by this paper
• Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion.

  2001cited by this paper
• N‐acetyl‐L‐cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis

  2000cited by this paper
• Expression of adenosine A2a receptors gene in the olfactory bulb and spinal cord of rat and mouse.

  1999cited by this paper
• Reduction of Lower Motor Neuron Degeneration inwobbler Mice byN-Acetyl-l-Cysteine

  1996cited by this paper
• Characterization of the AMP-activated Protein Kinase Kinase from Rat Liver and Identification of Threonine 172 as the Major Site at Which It Phosphorylates AMP-activated Protein Kinase*

  1996cited by this paper
• 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?

  1995cited by this paper
• Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons

  1992cited by this paper
• Intrathecal morphine in mice: a new technique.

  1980cited by this paper

• Adenosine Receptors in Neuroinflammation and Neurodegeneration

  2025cites this paper
• Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery

  2025cites this paper
• Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy

  2025cites this paper
• Oxidative Cysteine Post Translational Modifications Drive the Redox Code Underlying Neurodegeneration and Amyotrophic Lateral Sclerosis

  2024cites this paper
• Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis

  2024cites this paper
• Amyotrophic Lateral Sclerosis Mechanism: Insights from the Caenorhabditis elegans Models

  2024cites this paper
• Amyotrophic Lateral Sclerosis in Long-COVID Scenario and the Therapeutic Potential of the Purinergic System in Neuromodulation

  2024cites this paper
• The role of adiponectin-AMPK axis in TDP-43 mislocalization and disease severity in ALS.

  2024cites this paper
• PRKAG2 Variant, Motor Neuron Disease, and Parkinsonism: Fortuitous Association or a Potentially Underestimated Pathophysiological Mechanism?

  2024cites this paper
• HSP90 inhibition in the mouse spinal cord enhances opioid signaling by suppressing an AMPK-mediated negative feedback loop

  2023cites this paper
• Circulating proteomic biomarkers for diagnosing sporadic amyotrophic lateral sclerosis: a cross-sectional study

  2023cites this paper
• Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders.

  2023cites this paper
• Genome-Wide Gene-Set Analysis Identifies Molecular Mechanisms Associated with ALS

  2023cites this paper
• Impact of the Amyotrophic Lateral Sclerosis Disease on the Biomechanical Properties and Oxidative Stress Metabolism of the Lung Tissue Correlated With the Human Mutant SOD1G93A Protein Accumulation

  2022cites this paper
• Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Imaging Neurodegenerative Metabolism in Amyotrophic Lateral Sclerosis with Hyperpolarized [1-13C]pyruvate MRI

  2022cites this paper
• Demethyleneberberine, a potential therapeutic agent in neurodegenerative disorders: a proposed mechanistic insight

  2022cites this paper
• The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?

  2022cites this paper
• Defects of Nutrient Signaling and Autophagy in Neurodegeneration

  2022cites this paper
• Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders

  2022cites this paper
• Highlighting the protective or degenerative role of AMPK activators in dementia experimental models.

  2021cites this paper
• Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases

  2021cites this paper
• A system-wide mislocalization of RNA-binding proteins in motor neurons is a new feature of ALS.

  2021cites this paper
• How Are Adenosine and Adenosine A2A Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?

  2021influential citation
• Opposing roles of p38α-mediated phosphorylation and arginine methylation in driving TDP-43 proteinopathy

  2021cites this paper
• Contribution of Energy Dysfunction to Impaired Protein Translation in Neurodegenerative Diseases

  2021cites this paper
• The links between diabetes mellitus and amyotrophic lateral sclerosis

  2021influential citation
• Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis

  2020cites this paper
• Repeated intramuscular transplantations of hUCB-MSCs improves motor function and survival in the SOD1 G93A mice through activation of AMPK

  2020cites this paper
• Importance of lipids for upper motor neuron health and disease.

  2020cites this paper
• Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis

  2020cites this paper
• The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications

  2020cites this paper
• Existing and Emerging Metabolomic Tools for ALS Research

  2019cites this paper
• The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?

  2019cites this paper
• Adenosine and Its Receptors as Potential Drug Targets in Amyotrophic Lateral Sclerosis

  2019cites this paper
• Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis

  2018cites this paper
• Disease-modifying effects of metabolic perturbations in ALS/FTLD

  2018cites this paper
• GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons

  2018cites this paper
• Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease

  2018cites this paper
• Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors

  2018cites this paper
• The Role of AMPK in Neuromuscular Biology and Disease.

  2018cites this paper
• The D2 Dopamine Receptor Interferes With the Protective Effect of the A2A Adenosine Receptor on TDP-43 Mislocalization in Experimental Models of Motor Neuron Degeneration

  2018cites this paper
• Energy metabolism in ALS: an underappreciated opportunity?

  2018cites this paper
• TDP-43 post-translational modifications in health and disease

  2018cites this paper
• Photocontrollable Probe Spatiotemporally Induces Neurotoxic Fibrillar Aggregates and Impairs Nucleocytoplasmic Trafficking.

  2017cites this paper
• AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration.

  2017cites this paper
• AMPK signaling in the nucleus accumbens core mediates cue-induced reinstatement of cocaine seeking

  2017cites this paper
• What is “Hyper” in the ALS Hypermetabolism?

  2017cites this paper
• Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis

  2017influential citation
• Cysteine Modifications in the Pathogenesis of ALS

  2017cites this paper
• The Bioenergetic Engine : Muscle Metabolic Properties and Hypermetabolism in ALS

  2017cites this paper
• Folliculin, a tumor suppressor associated with Birt-Hogg-Dubé (BHD) syndrome, is a novel modifier of TDP-43 cytoplasmic translocation and aggregation.

  2016cites this paper
• AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis

  2016cites this paper
• ALS: A bucket of genes, environment, metabolism and unknown ingredients.

  2016cites this paper
• AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives.

  2016cites this paper
• Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies *

  2016cites this paper
• AMPK in Neurodegenerative Diseases.

  2016cites this paper
• Insulin resistance and Parkinson's disease: A new target for disease modification?

  2016influential citation
• 5'-AMP-activated protein kinase alpha regulates stress granule biogenesis.

  2015cites this paper
• Oxidative stress, redox homeostasis and NF-κB signaling in neurodegeneration

  2015cites this paper
• Structural modifications of the RNA-binding protein, fused in sarcoma : implications for amyotrophic lateral sclerosis

  2015cites this paper
• Modulations du métabolisme et de l’autophagie induites par l’exercice physique dans un modèle souris de sclérose latérale amyotrophique (SLA)

  2015influential citation
• Aberrant activation of AMP‐activated protein kinase contributes to the abnormal distribution of HuR in amyotrophic lateral sclerosis

  2015cites this paper
• AMPK-mediated regulation of neuronal metabolism and function in brain diseases

  2015influential citation
• Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43.

  2015cites this paper
• Characterization and real-time imaging of the FTLD-related protein aggregation induced by amyloidogenic peptides.

  2015cites this paper
• Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease

  2015cites this paper
• Silibinin activates AMP-activated protein kinase to protect neuronal cells from oxygen and glucose deprivation-re-oxygenation.

  2014cites this paper